In addition to its originally proposed roles in innate immunity, available evidence suggests that CARD9 plays novel regulatory roles in the development of glucose intolerance and insulin resistance in animal models of diet-induced obesity, glucose intolerance, and insulin resistance. Here, CARD9 is linked to obesity disorder.